13-24321454-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_178540.5(C1QTNF9):c.688G>A(p.Glu230Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000275 in 1,613,176 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_178540.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
C1QTNF9 | NM_178540.5 | c.688G>A | p.Glu230Lys | missense_variant | 4/4 | ENST00000332018.5 | |
C1QTNF9 | NM_001303137.2 | c.688G>A | p.Glu230Lys | missense_variant | 5/5 | ||
C1QTNF9 | NM_001303138.2 | c.688G>A | p.Glu230Lys | missense_variant | 4/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
C1QTNF9 | ENST00000332018.5 | c.688G>A | p.Glu230Lys | missense_variant | 4/4 | 1 | NM_178540.5 | P1 | |
C1QTNF9-AS1 | ENST00000449656.1 | n.73+72C>T | intron_variant, non_coding_transcript_variant | 5 | |||||
C1QTNF9 | ENST00000382071.6 | c.688G>A | p.Glu230Lys | missense_variant | 4/4 | 5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000291 AC: 44AN: 151434Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.000251 AC: 63AN: 251176Hom.: 1 AF XY: 0.000361 AC XY: 49AN XY: 135744
GnomAD4 exome AF: 0.000273 AC: 399AN: 1461624Hom.: 2 Cov.: 90 AF XY: 0.000298 AC XY: 217AN XY: 727130
GnomAD4 genome AF: 0.000290 AC: 44AN: 151552Hom.: 0 Cov.: 30 AF XY: 0.000324 AC XY: 24AN XY: 73972
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 06, 2021 | The c.688G>A (p.E230K) alteration is located in exon 4 (coding exon 3) of the C1QTNF9 gene. This alteration results from a G to A substitution at nucleotide position 688, causing the glutamic acid (E) at amino acid position 230 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at